A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC
A Phase 3 Randomized, Double-Blind Study of PF-06439535 Plus Paclitaxel-Carboplatin and Bevacizumab Plus Paclitaxel Carboplatin for the First-Line Treatment of Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
Category & Conditions: Cancer
Medicine: ZIRABEV INJECTION(BEVACIZUMAB-BVZR)
ClinicalTrials.gov Identifier (NCT): NCT02364999
Protocol ID: B7391003
PrintDownloadOpen Plain Language Summary Result: Click here